Wednesday, June 09, 2021 Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis. Bauman G, Ding K, Chin J, Nair S, Iaboni A, Crook J, Klotz L, Dearnaley D, Horwitz E, O'Callaghan C. Cureus 12: e7983, 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205382/ Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy. Pouliot F, Rouleau M, Neveu B, Toren P, Morin F, Vélot L, Ding K, Caron P, Lacombe L, Lévesque É, Klotz L, Guillemette C. Journal of Urology 203: 940-8, 2020. https://www.auajournals.org/doi/10.1097/JU.0000000000000699 Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial. Toren P, Hoffman A, Ding K, Joncas FH, Turcotte V, Caron P, Pouliot F, Fradet Y, Lévesque É, Guillemette C, Klotz L. Clin Cancer Res 24: 5305-12, 2018. https://clincancerres.aacrjournals.org/content/24/21/5305
